Sun Pharma up 2%; may approach US FDA for re-inspection of Halol

The company expects to approach the US FDA for a re-inspection of its Halol site by the first quarter of financial year 2017, Sun Pharma management reportedly said on investor call.

Sun Pharmaceutical Ltd stock was up by 2% at Rs. 863. The company expects to approach the US FDA for a re-inspection of its Halol site by the first quarter of financial year 2017, Sun Pharma management reportedly said on investor call.

The scrip opened at Rs. 853 and has touched a high and low of Rs. 867.1 and Rs. 853 respectively. So far 1721919(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 204169.51 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.7 on 07-Apr-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 884.25 and Rs. 803.55 respectively.

The promoters holding in the company stood at 54.97 % while Institutions and Non-Institutions held 35.25 % and 9.77 % respectively.

The stock is currently trading below its 200 DMA.